A Plus Biotechnology Co., Ltd. (TPE:6918)
Taiwan · Delayed Price · Currency is TWD 73.90
+0.20 (0.27%)
At close: Jun 18, 2026
A Plus Biotechnology Market Cap
A Plus Biotechnology has a market cap or net worth of 2.49 billion as of June 18, 2026. Its market cap has decreased by -18.28% in one year.
Market Cap
2.49B
Enterprise Value
2.04B
Revenue
858.89M
Ranking
n/a
PE Ratio
14.42
Stock Price
73.90
Market Cap Chart
Since January 6, 2023, A Plus Biotechnology's market cap has increased from 1.52B to 2.49B, an increase of 63.44%. That is a compound annual growth rate of 15.31%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 18, 2026 | 2.49B | -15.76% |
| Dec 31, 2025 | 2.96B | 20.95% |
| Dec 31, 2024 | 2.44B | 77.04% |
| Dec 29, 2023 | 1.38B | -9.40% |
| Jan 6, 2023 | 1.52B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Bonraybio | 3.36B |
| WeLeader Biomedical | 3.23B |
| Applied BioCode | 2.51B |
| Medimaging Integrated Solution | 2.41B |
| Wellell | 2.36B |
| OK Biotech | 2.12B |
| Dynamic Medical Technologies | 2.07B |
| Taiwan Biomaterial | 1.60B |